Sorkin A, Duex JE. Quantitative analysis of endocytosis and turnover of
epidermal growth factor (EGF) and EGF receptor. Curr Protoc Cell Biol. 2010
Mar;Chapter 15:Unit 15.14.
Vina-Vilaseca A, Sorkin A. Lysine 63-linked polyubiquitination of the dopamine
transporter requires WW3 and WW4 domains of Nedd4-2 and UBE2D
ubiquitin-conjugating enzymes. J Biol Chem. 2010 Mar 5;285(10):7645-56. Epub 2010
Jan 5.
Sorkin A, von Zastrow M. Endocytosis and signalling: intertwining molecular
networks. Nat Rev Mol Cell Biol. 2009 Sep;10(9):609-22. Review.
Price DA, Sorkin A, Zahniser NR. Cyclin-dependent kinase 5 inhibitors:
inhibition of dopamine transporter activity. Mol Pharmacol. 2009
Oct;76(4):812-23. Epub 2009 Jul 23.
Zahniser NR, Sorkin A. Trafficking of dopamine transporters in psychostimulant
actions. Semin Cell Dev Biol. 2009 Jun;20(4):411-7. Epub 2009 Jan 22. Review.
Sorkin A, Goh LK. Endocytosis and intracellular trafficking of ErbBs. Exp Cell
Res. 2009 Feb 15;315(4):683-96. Review.
Duex JE, Sorkin A. RNA interference screen identifies Usp18 as a regulator of
epidermal growth factor receptor synthesis. Mol Biol Cell. 2009
Mar;20(6):1833-44. Epub 2009 Jan 21.
Sorkin A, Goh LK. Endocytosis and intracellular trafficking of ErbBs. Exp Cell
Res. 2008 Oct 15;314(17):3093-106. Epub 2008 Aug 28. Review.
Galperin E, Sorkin A. Endosomal targeting of MEK2 requires RAF, MEK kinase
activity and clathrin-dependent endocytosis. Traffic. 2008 Sep;9(10):1776-90.
Epub 2008 Jul 24.
Sorkina T, Richards TL, Rao A, Zahniser NR, Sorkin A. Negative regulation of
dopamine transporter endocytosis by membrane-proximal N-terminal residues. J
Neurosci. 2009 Feb 4;29(5):1361-74.
